Sarah Elizabeth Turbett, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anaplasma phagocytophilum | 3 | 2022 | 37 | 2.250 |
Why?
|
Enterobacteriaceae | 5 | 2023 | 169 | 1.610 |
Why?
|
Anaplasmosis | 2 | 2022 | 36 | 1.530 |
Why?
|
Borrelia | 2 | 2023 | 67 | 1.130 |
Why?
|
Anti-Infective Agents | 2 | 2023 | 972 | 1.060 |
Why?
|
Hafnia | 1 | 2023 | 3 | 0.920 |
Why?
|
Enterobacteriaceae Infections | 3 | 2023 | 187 | 0.850 |
Why?
|
Feces | 4 | 2020 | 1401 | 0.810 |
Why?
|
Borrelia burgdorferi | 1 | 2023 | 180 | 0.800 |
Why?
|
Sin Nombre virus | 1 | 2020 | 3 | 0.750 |
Why?
|
Hantavirus Pulmonary Syndrome | 1 | 2020 | 10 | 0.750 |
Why?
|
Lyme Disease | 2 | 2023 | 621 | 0.750 |
Why?
|
Antibodies, Viral | 7 | 2022 | 3176 | 0.740 |
Why?
|
Ehrlichiosis | 1 | 2020 | 29 | 0.720 |
Why?
|
Coccidioidomycosis | 1 | 2020 | 36 | 0.720 |
Why?
|
Drug Resistance, Bacterial | 4 | 2023 | 1035 | 0.710 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 194 | 0.700 |
Why?
|
Bites and Stings | 1 | 2020 | 91 | 0.690 |
Why?
|
Lung Diseases, Fungal | 1 | 2020 | 122 | 0.680 |
Why?
|
Pancytopenia | 1 | 2020 | 104 | 0.670 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2020 | 236 | 0.650 |
Why?
|
Organ Transplantation | 3 | 2023 | 1139 | 0.650 |
Why?
|
Exanthema | 4 | 2018 | 501 | 0.640 |
Why?
|
Roseolovirus Infections | 1 | 2018 | 45 | 0.640 |
Why?
|
Herpesvirus 6, Human | 1 | 2018 | 95 | 0.620 |
Why?
|
Glomerulonephritis | 1 | 2020 | 372 | 0.610 |
Why?
|
Tenosynovitis | 1 | 2017 | 57 | 0.600 |
Why?
|
Leptospirosis | 1 | 2017 | 29 | 0.600 |
Why?
|
Antifungal Agents | 1 | 2022 | 730 | 0.590 |
Why?
|
Aortitis | 2 | 2014 | 74 | 0.570 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2020 | 220 | 0.560 |
Why?
|
Fever | 6 | 2022 | 1616 | 0.530 |
Why?
|
Specimen Handling | 1 | 2020 | 694 | 0.530 |
Why?
|
Neisseria gonorrhoeae | 1 | 2017 | 238 | 0.500 |
Why?
|
Communicable Diseases | 1 | 2023 | 880 | 0.500 |
Why?
|
beta-Lactamases | 6 | 2023 | 306 | 0.480 |
Why?
|
Lung | 5 | 2022 | 9856 | 0.480 |
Why?
|
Diagnosis, Differential | 9 | 2022 | 12959 | 0.470 |
Why?
|
Syphilis | 1 | 2016 | 227 | 0.470 |
Why?
|
Arthritis, Infectious | 1 | 2017 | 367 | 0.460 |
Why?
|
Gonorrhea | 1 | 2017 | 335 | 0.450 |
Why?
|
Endocarditis, Bacterial | 2 | 2014 | 455 | 0.440 |
Why?
|
Sepsis | 2 | 2024 | 2593 | 0.430 |
Why?
|
Dyspnea | 1 | 2020 | 1303 | 0.420 |
Why?
|
Colistin | 2 | 2023 | 47 | 0.400 |
Why?
|
Travel | 4 | 2023 | 788 | 0.380 |
Why?
|
Aorta | 2 | 2014 | 2061 | 0.340 |
Why?
|
Staphylococcal Infections | 2 | 2014 | 1400 | 0.310 |
Why?
|
Decision Making | 1 | 2022 | 3887 | 0.310 |
Why?
|
Cough | 2 | 2022 | 555 | 0.300 |
Why?
|
Aortic Valve | 2 | 2014 | 1922 | 0.300 |
Why?
|
Lymph Nodes | 1 | 2018 | 3474 | 0.290 |
Why?
|
Myocardium | 1 | 2020 | 4776 | 0.280 |
Why?
|
Bacteremia | 2 | 2024 | 962 | 0.250 |
Why?
|
Pneumonia | 3 | 2022 | 2133 | 0.250 |
Why?
|
Diarrhea | 2 | 2022 | 1348 | 0.250 |
Why?
|
Serologic Tests | 2 | 2023 | 374 | 0.250 |
Why?
|
Humans | 48 | 2024 | 744343 | 0.250 |
Why?
|
Immunoglobulin M | 3 | 2023 | 1537 | 0.230 |
Why?
|
Skin | 2 | 2014 | 4364 | 0.230 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 1978 | 0.230 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2024 | 40 | 0.230 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 56 | 0.230 |
Why?
|
Bedding and Linens | 1 | 2023 | 41 | 0.220 |
Why?
|
Klebsiella Infections | 1 | 2024 | 138 | 0.220 |
Why?
|
Radiography, Thoracic | 2 | 2020 | 1265 | 0.210 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 165 | 0.210 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7659 | 0.200 |
Why?
|
Anti-Bacterial Agents | 7 | 2024 | 7181 | 0.200 |
Why?
|
Sensitivity and Specificity | 5 | 2024 | 14722 | 0.200 |
Why?
|
Antibodies, Bacterial | 2 | 2023 | 1470 | 0.190 |
Why?
|
Peromyscus | 1 | 2020 | 18 | 0.190 |
Why?
|
Fatal Outcome | 3 | 2020 | 1850 | 0.180 |
Why?
|
Transplants | 1 | 2022 | 209 | 0.180 |
Why?
|
Bone Marrow Examination | 1 | 2020 | 157 | 0.180 |
Why?
|
Patient Isolation | 1 | 2020 | 100 | 0.180 |
Why?
|
Microbial Sensitivity Tests | 2 | 2023 | 1877 | 0.180 |
Why?
|
Lung Transplantation | 2 | 2019 | 1153 | 0.170 |
Why?
|
Escherichia coli | 2 | 2023 | 4217 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2023 | 3870 | 0.170 |
Why?
|
Malacoplakia | 1 | 2019 | 15 | 0.170 |
Why?
|
Microbial Viability | 1 | 2020 | 234 | 0.170 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 634 | 0.170 |
Why?
|
Carbapenems | 1 | 2020 | 118 | 0.170 |
Why?
|
Chills | 1 | 2018 | 16 | 0.170 |
Why?
|
Blood Cell Count | 1 | 2020 | 403 | 0.170 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 424 | 0.170 |
Why?
|
Leukocytosis | 1 | 2020 | 247 | 0.170 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 329 | 0.160 |
Why?
|
Culture Media | 1 | 2020 | 908 | 0.160 |
Why?
|
Immune Evasion | 1 | 2022 | 360 | 0.160 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2020 | 214 | 0.160 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.150 |
Why?
|
Infectious Disease Incubation Period | 1 | 2017 | 17 | 0.150 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 768 | 0.150 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1171 | 0.150 |
Why?
|
Indonesia | 1 | 2017 | 119 | 0.150 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2022 | 602 | 0.150 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 1972 | 0.150 |
Why?
|
Tretinoin | 1 | 2020 | 517 | 0.150 |
Why?
|
Genome, Viral | 1 | 2020 | 667 | 0.140 |
Why?
|
Thorax | 1 | 2020 | 547 | 0.140 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4560 | 0.140 |
Why?
|
Candida | 1 | 2017 | 172 | 0.140 |
Why?
|
Syphilis Serodiagnosis | 1 | 2016 | 35 | 0.140 |
Why?
|
Disease Outbreaks | 2 | 2023 | 1772 | 0.140 |
Why?
|
Leukocyte Count | 1 | 2020 | 1588 | 0.140 |
Why?
|
Synovial Fluid | 1 | 2017 | 394 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Candidiasis | 1 | 2017 | 366 | 0.130 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2016 | 134 | 0.120 |
Why?
|
Cross Infection | 1 | 2024 | 1416 | 0.120 |
Why?
|
Ankle | 1 | 2017 | 327 | 0.120 |
Why?
|
Bronchoscopy | 1 | 2020 | 862 | 0.120 |
Why?
|
Thrombocytopenia | 2 | 2020 | 1179 | 0.120 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 231 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.120 |
Why?
|
Temperature | 1 | 2020 | 2206 | 0.120 |
Why?
|
Abdomen | 1 | 2020 | 1118 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2019 | 847 | 0.110 |
Why?
|
Arthritis, Psoriatic | 1 | 2016 | 215 | 0.110 |
Why?
|
Algorithms | 3 | 2023 | 13881 | 0.110 |
Why?
|
Phylogeny | 1 | 2020 | 2803 | 0.110 |
Why?
|
Edema | 1 | 2017 | 789 | 0.110 |
Why?
|
Uveitis | 1 | 2016 | 375 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2749 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20129 | 0.100 |
Why?
|
Hand | 1 | 2017 | 884 | 0.100 |
Why?
|
Arthritis | 1 | 2017 | 659 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1199 | 0.100 |
Why?
|
Middle Aged | 10 | 2022 | 213383 | 0.100 |
Why?
|
New England | 2 | 2024 | 1022 | 0.090 |
Why?
|
Male | 13 | 2020 | 350118 | 0.090 |
Why?
|
Headache | 1 | 2017 | 1226 | 0.090 |
Why?
|
Tissue and Organ Procurement | 1 | 2017 | 896 | 0.090 |
Why?
|
Cross Reactions | 2 | 2022 | 841 | 0.090 |
Why?
|
Vision Disorders | 1 | 2016 | 1058 | 0.080 |
Why?
|
Hearing Loss | 1 | 2016 | 765 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2024 | 77449 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2282 | 0.080 |
Why?
|
Genotype | 1 | 2022 | 12951 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6756 | 0.070 |
Why?
|
Mass Screening | 1 | 2022 | 5255 | 0.070 |
Why?
|
Heart Transplantation | 1 | 2019 | 3110 | 0.070 |
Why?
|
Ultrasonography | 1 | 2018 | 5985 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15076 | 0.060 |
Why?
|
Monkeypox virus | 1 | 2023 | 48 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Young Adult | 2 | 2020 | 56430 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Pain | 1 | 2017 | 4986 | 0.050 |
Why?
|
beta-Lactams | 1 | 2023 | 160 | 0.050 |
Why?
|
Klebsiella pneumoniae | 1 | 2024 | 251 | 0.050 |
Why?
|
Female | 8 | 2023 | 380194 | 0.050 |
Why?
|
Coloring Agents | 1 | 2023 | 566 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 322 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 401 | 0.050 |
Why?
|
Metagenomics | 1 | 2024 | 428 | 0.050 |
Why?
|
Drug Resistance, Microbial | 1 | 2023 | 862 | 0.050 |
Why?
|
Metagenome | 1 | 2023 | 418 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 780 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2016 | 4256 | 0.050 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 675 | 0.040 |
Why?
|
HIV Infections | 2 | 2016 | 16718 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.040 |
Why?
|
North America | 1 | 2022 | 1249 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40075 | 0.040 |
Why?
|
Hepatic Encephalopathy | 1 | 2019 | 139 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 571 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2020 | 323 | 0.040 |
Why?
|
Animals | 2 | 2020 | 168757 | 0.040 |
Why?
|
Boston | 2 | 2020 | 9313 | 0.040 |
Why?
|
Bacterial Proteins | 2 | 2022 | 3848 | 0.040 |
Why?
|
Hospitals | 2 | 2022 | 3952 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 2011 | 0.040 |
Why?
|
Seasons | 1 | 2023 | 1493 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2020 | 992 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13695 | 0.040 |
Why?
|
Syndrome | 1 | 2023 | 3251 | 0.040 |
Why?
|
Heart Failure | 1 | 2020 | 10900 | 0.030 |
Why?
|
JC Virus | 1 | 2016 | 85 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2571 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1053 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.030 |
Why?
|
United States | 4 | 2023 | 69872 | 0.030 |
Why?
|
Rocky Mountain Spotted Fever | 1 | 2014 | 19 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Adult | 3 | 2022 | 214055 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 2959 | 0.030 |
Why?
|
Mice | 1 | 2020 | 81183 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2022 | 1940 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8388 | 0.030 |
Why?
|
Confusion | 1 | 2014 | 275 | 0.030 |
Why?
|
Models, Molecular | 1 | 2022 | 5456 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3597 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2114 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2024 | 5317 | 0.020 |
Why?
|
Massachusetts | 1 | 2023 | 8663 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2559 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1352 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9386 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7301 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2603 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3218 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2014 | 804 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5720 | 0.020 |
Why?
|
Mutation | 2 | 2023 | 29786 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 1133 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2016 | 1873 | 0.020 |
Why?
|
Aged | 4 | 2020 | 163280 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 72290 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2014 | 1451 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15226 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4386 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
Infant | 1 | 2023 | 35136 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.010 |
Why?
|
Kidney | 1 | 2014 | 7186 | 0.010 |
Why?
|
HIV-1 | 1 | 2016 | 6939 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40561 | 0.010 |
Why?
|